Article History
Received: 1 February 2026
Accepted: 18 April 2026
First Online: 20 May 2026
Declarations
:
: This is a retrospective study. The University of Michigan Institutional Review Board has confirmed that no ethical approval is required (HUM00169453).
: NLH reports consulting for AstraZeneca, Daiichi Sankyo, Genentech, and Novartis, and receives royalties from Up-to-Date, none of which are relevant to this manuscript. The other authors have no conflicts of interest to declare.